TCTMD

Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease

Spectranetics Corporation today announced that it plans to initiate the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial ...
Business Wire

Spectranetics Introduces First Advanced System for Simulation of Laser Assisted Lead Extractions

DENVER--(BUSINESS WIRE)--HEART RHYTHM 2010 – Spectranetics Corporation (NASDAQ:SPNC) today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society ...
TCTMD

Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis

COLORADO SPRINGS, Colo., The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its peripheral atherectomy product, the ...
Medscape

A Good Report Card for Laser-Assisted Pacemaker/ICD Lead Extraction

February 5, 2010 (Washington, DC) — Transvenous extraction of implanted-device leads using a laser catheter is nearly always completed successfully and poses little risk of death or other major ...
The Gazette

Spectranetics survives challenges to become company worth nearly $1B

Renee Dicks works on stranding laser catheters which may be used to vaporize arterial blockages or assist with removing the flexible cord that connects a pacemaker to the heart, known as a lead, at ...
Medscape

FDA approves more powerful Spectranetics laser catheter

Colorado Springs, CO The Spectranetics Corporation announced today that it has received FDA approval to market its Point 9 catheters with more laser energy than previously used. The Point 9 catheter ...
The Gazette

Medical laser manufacturer Spectranetics agrees to pay nearly $8.9 million to settle pair of legal claims

Spectranetics Corp., the Colorado Springs-based medical laser manufacturer, said Tuesday it has agreed to pay nearly $8.9 million to settle a pair of legal actions brought by stockholders against the ...
FierceBiotech

Spectranetics shares slump as the medical laser maker snips forecast

Shares of Spectranetics ($SPNC), the maker of medical lasers, hit a 6-month low in heavy trading after it reported lower quarterly earnings and trimmed its forecast ...
JD Supra

Spectranetics Announces FDA Approval for Turbo-Power™ Laser Atherectomy Catheter Device

According to a recent press release, Colorado Springs-based Spectranetics announced that it has received FDA 510(k) clearance for its Turbo-Power™ Laser Atherectomy Catheter, a peripheral atherectomy ...
Seeking Alpha

The Spectranetics Corporation Q1 2009 Earnings Call Transcript

Laser revenue declined 12% to $1.5 million due primarily to [2P] laser sales, as compared with last year. Net laser placements, which includes sold units as well as units placed under rental and other ...
BioWorld

Philips set to acquire Spectranetics for $2.2B ahead of Stellarex approval

Royal Phillips NV is set to acquire Spectranetics Corp. for €1.9 billion ($2.2 billion). The proposed acquisition is the latest in a string of efforts the Amsterdam, the Netherlands-based company has ...
Business Wire

Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease

The study will compare the safety and efficacy of excimer laser atherectomy utilizing the Spectranetics’ Turbo-Tandem and Turbo Elite products in conjunction with balloon angioplasty, with that of ...